The aim of the study was to establish the frequency and possible predictors of cardiovascular disease (CVD) in chronic kidney disease (CKD) VD stage patients, treated with hemodialysis, based on results of prospective observation. The prospective observational cohort study included 223 patients with CKD V D stage who were treated with hemodialysis (HD) during 2012-2019. The research was carried out in two stages. At the first stage, main demographic, laboratory and clinical characteristics of patients, including the frequency of CVD, at the time of beginning the study were examined. At the second stage, based on prospective studying of the dynamics of the frequency of CV pathology, an assessment of potential predictors of CVD in CKD V D st...
Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular disease (CVD), su...
Chronic kidney disease (CKD) is currently defined as the presence of proteinuria and/or an eGFR<60 m...
Julian Wright, Alastair HutchisonManchester Institute of Nephrology and Transplantation, Manchester ...
The aim of the study was to establish the frequency and possible predictors of cardiovascular diseas...
Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD).BackgroundTradi...
Chronic kidney disease (CKD) is a long term condition in which glomerular filtration is reduced and/...
Objective: Cardiovascular disease (CVD) is the main cause of morbidity and premature mortality in en...
Hemodialysis (HD) is the main treatment modality for patients with end-stage kidney disease. Cardiov...
Purpose of reviewCardiovascular disease (CVD) is the leading cause of death in patients with chronic...
The evolution of cardiovascular diseases among patients with chronic kidney disease (CKD) not requir...
Aim. To evaluate the frequency and effects on prognosis of conventional and optional cardiovascular ...
Background: Cardiovascular disease (CVD) is the main cause of death in the chronic kidney disease (C...
Patients with chronic kidney disease have a high burden of cardiovascular morbidity and mortality. T...
Based on global cardiovascular (CV) risk assessment for example using the Framingham risk score, it ...
Based on global cardiovascular (CV) risk assessment for example using the Framingham risk score, it ...
Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular disease (CVD), su...
Chronic kidney disease (CKD) is currently defined as the presence of proteinuria and/or an eGFR<60 m...
Julian Wright, Alastair HutchisonManchester Institute of Nephrology and Transplantation, Manchester ...
The aim of the study was to establish the frequency and possible predictors of cardiovascular diseas...
Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD).BackgroundTradi...
Chronic kidney disease (CKD) is a long term condition in which glomerular filtration is reduced and/...
Objective: Cardiovascular disease (CVD) is the main cause of morbidity and premature mortality in en...
Hemodialysis (HD) is the main treatment modality for patients with end-stage kidney disease. Cardiov...
Purpose of reviewCardiovascular disease (CVD) is the leading cause of death in patients with chronic...
The evolution of cardiovascular diseases among patients with chronic kidney disease (CKD) not requir...
Aim. To evaluate the frequency and effects on prognosis of conventional and optional cardiovascular ...
Background: Cardiovascular disease (CVD) is the main cause of death in the chronic kidney disease (C...
Patients with chronic kidney disease have a high burden of cardiovascular morbidity and mortality. T...
Based on global cardiovascular (CV) risk assessment for example using the Framingham risk score, it ...
Based on global cardiovascular (CV) risk assessment for example using the Framingham risk score, it ...
Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular disease (CVD), su...
Chronic kidney disease (CKD) is currently defined as the presence of proteinuria and/or an eGFR<60 m...
Julian Wright, Alastair HutchisonManchester Institute of Nephrology and Transplantation, Manchester ...